{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:56:02Z","timestamp":1790556962959,"version":"4.1.0"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"\n BACKGROUND<\/jats:title>\n Routine urine substance screening (USS) in pregnant women for perinatal substance exposure is associated with bias and has limited evidence supporting its use. We evaluated agreement between maternal disclosure, maternal and neonatal USS, and their predictive abilities for neonatal opioid withdrawal syndrome (NOWS) admission.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n In this single-center retrospective study, we included pregnant women with gestational substance use and their neonates (February 2018 to December 2022). Agreement between screening tests was assessed using \u03ba. Predictive abilities of the screening were evaluated using logistic regression and area under the receiver operating characteristic curve (AUC).<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n We analyzed 1161 paired maternal USS and maternal disclosure of substance use and 907 paired maternal and neonatal USS results. Self-disclosure and maternal USS showed moderate agreement for opioids (\u03ba = 0.54) and substantial agreement for methadone (\u03ba = 0.80). Maternal and neonatal USS demonstrated moderate agreement for opioids (\u03ba = 0.67) and almost perfect agreement for methadone (\u03ba = 0.88). Among 952 infants born during the study period, 277 (29%) were admitted for NOWS and 176 (18.4%) required pharmacotherapy. Odds ratio (OR) for NOWS admission for self-disclosure, maternal USS, and neonatal USS were 9.9, 8.5, and 6.2, and the AUC for the same were 0.75, 0.74, and 0.71, respectively. Combined maternal history and maternal USS provided the strongest prediction (OR, 12.0; AUC, 0.78), whereas combined maternal disclosure, maternal USS, and neonatal USS had an OR of 10.8 and AUC of 0.75.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n Maternal self-disclosure demonstrated moderate agreement with maternal USS for perinatal opioid exposure. Although combining maternal self-disclosure with maternal USS provided the highest predictive ability for neonatal admission with NOWS, maternal self-disclosure alone remained a reliable predictor.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/hpeds.2025-009186","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:03:06Z","timestamp":1790553786000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictive Performance of Screening Methods for Neonatal Opioid Withdrawal Syndrome"],"prefix":"10.1542","author":[{"given":"Courtney W.","family":"Tam","sequence":"first","affiliation":[{"name":"1Division of Newborn Medicine, Los Angeles General Medical Center, Department of Pediatrics, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Venvertloh","sequence":"additional","affiliation":[{"name":"2St Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona"},{"name":"3Department of Pediatrics, Creighton University Medical School, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Witsoe","sequence":"additional","affiliation":[{"name":"2St Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona"},{"name":"3Department of Pediatrics, Creighton University Medical School, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.E.","family":"Rossi","sequence":"additional","affiliation":[{"name":"2St Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona"},{"name":"3Department of Pediatrics, Creighton University Medical School, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cogua","sequence":"additional","affiliation":[{"name":"2St Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona"},{"name":"3Department of Pediatrics, Creighton University Medical School, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Kasten","sequence":"additional","affiliation":[{"name":"2St Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona"},{"name":"3Department of Pediatrics, Creighton University Medical School, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanuyen","family":"Pham","sequence":"additional","affiliation":[{"name":"2St Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona"},{"name":"3Department of Pediatrics, Creighton University Medical School, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concepcion","family":"Mendoza","sequence":"additional","affiliation":[{"name":"1Division of Newborn Medicine, Los Angeles General Medical Center, Department of Pediatrics, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kang","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Creighton University Medical School, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Yeh","sequence":"additional","affiliation":[{"name":"1Division of Newborn Medicine, Los Angeles General Medical Center, Department of Pediatrics, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena","family":"Cayabyab","sequence":"additional","affiliation":[{"name":"1Division of Newborn Medicine, Los Angeles General Medical Center, Department of Pediatrics, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemananda","family":"Muniraman","sequence":"additional","affiliation":[{"name":"1Division of Newborn Medicine, Los Angeles General Medical Center, Department of Pediatrics, University of Southern California, Los Angeles, California"},{"name":"2St Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona"},{"name":"3Department of Pediatrics, Creighton University Medical School, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"2","key":"2026092720030117300_r1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000485","article-title":"Detection of drug-exposed newborns","volume":"40","author":"Wabuyele","year":"2018","journal-title":"Ther Drug Monit."},{"key":"2026092720030117300_r2","article-title":"Substance Abuse and Mental Health Services Administration","author":"2023 National Survey on Drug Use and Health (NSDUH) releases","year":"2025"},{"issue":"2","key":"2026092720030117300_r3","doi-asserted-by":"crossref","first-page":"e2023062871","DOI":"10.1542\/peds.2023-062871","article-title":"Advances in the care of infants with prenatal opioid exposure and neonatal opioid withdrawal syndrome","volume":"153","author":"Mascarenhas","year":"2024","journal-title":"Pediatrics."},{"issue":"1","key":"2026092720030117300_r4","doi-asserted-by":"crossref","first-page":"e2023063635","DOI":"10.1542\/peds.2023-063635","article-title":"Neonatal opioid withdrawal syndrome treatment guidelines and birth hospital utilization","volume":"154","author":"Hahn","year":"2024","journal-title":"Pediatrics."},{"key":"2026092720030117300_r5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpeds.2021.12.021","article-title":"Standardizing the clinical definition of opioid withdrawal in the neonate","volume":"243","author":"Jilani","year":"2022","journal-title":"J Pediatr."},{"issue":"5","key":"2026092720030117300_r6","doi-asserted-by":"crossref","first-page":"e2020029074","DOI":"10.1542\/peds.2020-029074","article-title":"Neonatal opioid withdrawal syndrome","volume":"146","author":"Patrick","year":"2020","journal-title":"Pediatrics."},{"issue":"2","key":"2026092720030117300_r7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000485","article-title":"Detection of drug-exposed newborns","volume":"40","author":"Wabuyele","year":"2018","journal-title":"Ther Drug Monit."},{"key":"2026092720030117300_r8","article-title":"The American College of Obstetricians and Gynecologists","author":"Substance use disorder in pregnancy"},{"key":"2026092720030117300_r9","article-title":"ACOG Committee Opinion: Opioid Use and Opioid Use Disorder in Pregnancy","volume":"711","author":"Committee on Obstetric Practice; American Society of Addiction Medicine","year":"2017"},{"key":"2026092720030117300_r10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3389\/fphar.2018.00961","article-title":"Screening pregnant women and their neonates for illicit drug use: consideration of the integrated technical, medical, ethical, legal, and social issues","volume":"9","author":"Price","year":"2018","journal-title":"Front Pharmacol."},{"key":"2026092720030117300_r11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.acc.2016.11.003","article-title":"Rapid assessment of drugs of abuse","volume":"80","author":"Wiencek","year":"2017","journal-title":"Adv Clin Chem."},{"key":"2026092720030117300_r12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpeds.2018.09.046","article-title":"Umbilical cord tissue and meconium may not be equivalent for confirming in utero substance exposure","volume":"205","author":"Colby","year":"2019","journal-title":"J Pediatr."},{"issue":"9","key":"2026092720030117300_r13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14651","article-title":"Accuracy of five self-report screening instruments for substance use in pregnancy","volume":"114","author":"Ondersma","year":"2019","journal-title":"Addiction."},{"issue":"5","key":"2026092720030117300_r14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/AOG.0000000000003230","article-title":"Accuracy of three screening tools for prenatal substance use","volume":"133","author":"Coleman-Cowger","year":"2019","journal-title":"Obstet Gynecol."},{"issue":"3","key":"2026092720030117300_r15","doi-asserted-by":"crossref","first-page":"e2024068612","DOI":"10.1542\/peds.2024-068612","article-title":"Maternal and infant opioid screening for neonates at risk","volume":"156","author":"Witcher","year":"2025","journal-title":"Pediatrics."},{"issue":"7","key":"2026092720030117300_r16","doi-asserted-by":"crossref","first-page":"100963","DOI":"10.1016\/j.ajogmf.2023.100963","article-title":"Assessing the clinical utility of toxicology testing in the peripartum period","volume":"5","author":"Siegel","year":"2023","journal-title":"Am J Obstet Gynecol MFM."},{"issue":"5","key":"2026092720030117300_r17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/14659891003721133","article-title":"Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women","volume":"16","author":"Yonkers","year":"2011","journal-title":"J Subst Use."},{"issue":"1","key":"2026092720030117300_r18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ADM.0000000000001230","article-title":"Agreement between self-reports and urine toxicology measures of illicit methamphetamine and cocaine use during early pregnancy","volume":"18","author":"Sujan","year":"2024","journal-title":"J Addict Med."},{"issue":"1","key":"2026092720030117300_r19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12978-017-0385-3","article-title":"Prevalence of prenatal exposure to substances of abuse: questionnaire versus biomarkers","volume":"14","author":"Chiandetti","year":"2017","journal-title":"Reprod Health."},{"issue":"9","key":"2026092720030117300_r20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/add.16200","article-title":"Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis","volume":"118","author":"Bharat","year":"2023","journal-title":"Addiction."},{"issue":"3","key":"2026092720030117300_r21","doi-asserted-by":"crossref","first-page":"e20164070","DOI":"10.1542\/peds.2016-4070","article-title":"A public health response to opioid use in pregnancy","volume":"139","author":"Patrick","year":"2017","journal-title":"Pediatrics."},{"issue":"5","key":"2026092720030117300_r22","first-page":"547","article-title":"Substance use disorder in pregnancy","volume":"107","author":"Fitzgerald","year":"2023","journal-title":"Am Fam Physician."},{"issue":"2","key":"2026092720030117300_r23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jogn.2024.01.007","article-title":"Drug testing of pregnant patients","volume":"53","author":"Cleveland","year":"2024","journal-title":"J Obstet Gynecol Neonatal Nurs."},{"key":"2026092720030117300_r24","article-title":"Substance Use During Pregnancy and Child Abuse or Neglect: Summary of State Laws","author":"Legislative Analysis and Public Policy Association","year":"2024"},{"issue":"1","key":"2026092720030117300_r25","doi-asserted-by":"crossref","first-page":"100453","DOI":"10.1016\/j.ajogmf.2021.100453","article-title":"Racial differences in indications for obstetrical toxicology testing and relationship of indications to test results","volume":"4","author":"Perlman","year":"2022","journal-title":"Am J Obstet Gynecol MFM."},{"issue":"3","key":"2026092720030117300_r26","doi-asserted-by":"crossref","first-page":"e250908","DOI":"10.1001\/jamanetworkopen.2025.0908","article-title":"Racial equity in urine drug screening policies in labor and delivery","volume":"8","author":"Azimi","year":"2025","journal-title":"JAMA Netw Open."},{"issue":"4","key":"2026092720030117300_r27","doi-asserted-by":"crossref","first-page":"e2024068673","DOI":"10.1542\/peds.2024-068673","article-title":"Adapting a risk prediction tool for neonatal opioid withdrawal syndrome","volume":"155","author":"Reese","year":"2025","journal-title":"Pediatrics."},{"issue":"1","key":"2026092720030117300_r28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.physio.2013.08.002","article-title":"Pitfalls in the use of kappa when interpreting agreement between multiple raters in reliability studies","volume":"100","author":"O\u2019Leary","year":"2014","journal-title":"Physiotherapy."},{"issue":"7","key":"2026092720030117300_r29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1542\/hpeds.2022-006806","article-title":"Implementation of ESC QI initiative in neonatal unit setting and adaptation during the pandemic","volume":"13","author":"Small","year":"2023","journal-title":"Hosp Pediatr."}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/doi\/10.1542\/hpeds.2025-009186\/1968661\/hosppeds.2025009186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/doi\/10.1542\/hpeds.2025-009186\/1968661\/hosppeds.2025009186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:03:09Z","timestamp":1790553789000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/doi\/10.1542\/hpeds.2025-009186\/210089\/Predictive-Performance-of-Screening-Methods-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1542\/hpeds.2025-009186","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"e2025009186"}}